| 2026 | Standardizing the Accuracy and Performance Evaluation Metrics of Integrated Continuous Glucose Monitors in the Asia-Pacific Region | DIABETES TECHNOLOGY & THERAPEUTICS |
| 2026 | Efficacy and safety of adding a fourth oral antidiabetic drug versus metformin dose escalation in patients with type 2 diabetes inadequately controlled on triple oral combination therapy (EFFORT): A 24-week, randomized, open-label, multicenter trial | DIABETES OBESITY & METABOLISM |
| 2025 | Impact of Type 2 Diabetes Mellitus on Age at Death in the Hemodialysis Population: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018
| DIABETOLOGY |
| 2025 | Protective Role of Serum β-Hydroxybutyrate in Early Diabetic Kidney Disease: A Longitudinal Study
| DIABETES THERAPY |
| 2025 | Bridging Evidence and Practice: A Consensus Statement from the Korean Diabetes Association on Diabetes Screening, Pharmacological Treatment and Severe Diabetes
| DIABETES & METABOLISM JOURNAL |
| 2025 | Trends in Prevalence of Obesity and Related Cardiometabolic and Renal Complications in Korea: A Nationwide Study 2007 to 2022
| JOURNAL OF OBESITY & METABOLIC SYNDROME |
| 2025 | Safety and effectiveness of pregabalin controlled-release in Korean patients with peripheral neuropathic pain: A post-marketing surveillance data
| MEDICINE |
| 2025 | Efficacy and safety in tirzepatide-treated Korean adults with type 2 diabetes-A post hoc analysis of SURPASS-AP-combo and SURPASS-3
| DIABETES OBESITY & METABOLISM |
| 2025 | The Impact of Ketogenic Capacity on Lipid Profile in Individuals with Prediabetes or Newly Diagnosed Type 2 Diabetes
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2025 | DA-9701 (Motilitone®) improves glucose homeostasis by protecting STZ-induced β-cells death | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS |
| 2025 | Efficacy and safety of pioglitazone, empagliflozin and glimepiride as third-line agents in patients with type 2 diabetes inadequately controlled with metformin and DPP-4 inhibitors: A multicentre, phase 4 randomized controlled trial | DIABETES OBESITY & METABOLISM |
| 2025 | Meeting Physical Activity Guidelines: Impact on Chronic Kidney Disease Prevalence in Diabetic Individuals
| YONSEI MEDICAL JOURNAL |
| 2025 | 2025 Clinical Practice Guidelines for Diabetes Management in Korea: Recommendation of the Korean Diabetes Association
| DIABETES & METABOLISM JOURNAL |
| 2025 | Ketone Body Induction: Insights into Metabolic Disease Management
| BIOMEDICINES |
| 2025 | Impact of physical activities in metabolic dysfunction associated steatotic liver disease, sarcopenia, and cardiovascular disease | DIABETES RESEARCH AND CLINICAL PRACTICE |
| 2025 | Synergistic benefit of thiazolidinedione and sodium-glucose cotransporter 2 inhibitor for metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: a 24-week, open-label, randomized controlled trial
| BMC MEDICINE |
| 2025 | SCOPE of Cardiometabolic Health in Asia-Pacific: Shaping Cardiometabolic Outcomes With Personalized Treatment Strategies and Patient Empowerment
| JOURNAL OF ENDOCRINOLOGY AND METABOLISM |
| 2025 | Effectiveness and Safety of Oral Quadruple Combination Therapy in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
| Endocrinology and Metabolism(대한내분비학회지) |
| 2025 | Association between serum beta-hydroxybutyrate levels and risk of type 2 diabetes mellitus in patients with impaired fasting glucose
| NUTRITION & DIABETES |
| 2025 | Potential Impact of Choline Alphoscerate on Depressive Symptoms in Association with Insulin Resistance in Elderly Patients with Type 2 Diabetes
| JOURNAL OF CLINICAL MEDICINE |
| 2025 | Efficacy and Safety of Finerenone in Asian Patients with Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis | KIDNEY DISEASES |
| 2025 | Efficacy and safety of a fixed-dose combination of dapagliflozin and linagliptin (AJU-A51) in patients with type 2 diabetes mellitus: A multicentre, randomized, double-blind, parallel-group, placebo-controlled phase III study
| DIABETES OBESITY & METABOLISM |
| 2024 | Causal effect of fasting serum glucose on atherosclerotic cardiovascular disease: a multivariable Mendelian randomization
| EPIDEMIOLOGY AND HEALTH |
| 2024 | Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: A Review and Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
| DIABETES & METABOLISM JOURNAL |
| 2024 | SGLT2 Inhibitor Use and Risk of Dementia and Parkinson Disease Among Patients With Type 2 Diabetes | NEUROLOGY |
| 2024 | Efficacy and Safety of Pioglitazone Add-on in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin and Dapagliflozin: A Multicenter, Randomized, Double-blind, and Placebo-controlled Study | CLINICAL THERAPEUTICS |
| 2024 | 2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association
| DIABETES & METABOLISM JOURNAL |
| 2024 | A 52-week efficacy and safety study of enavogliflozin versus dapagliflozin as an add-on to metformin in patients with type 2 diabetes mellitus: ENHANCE-M extension study | DIABETES OBESITY & METABOLISM |
| 2024 | The Efficacy and Tolerability of Irbesartan/Amlodipine Combination Therapy in Patients With Essential Hypertension Whose Blood Pressure Were not Controlled by Irbesartan Monotherapy
| CLINICAL THERAPEUTICS |
| 2024 | Safety and Effectiveness of Dulaglutide in the Treatment of Type 2 Diabetes Mellitus: A Korean Real-World Post-Marketing Study
| DIABETES & METABOLISM JOURNAL |
| 2024 | Appendicular Skeletal Muscle Mass to Visceral Fat Area Ratio Predicts Hepatic Morbidities
| GUT AND LIVER |
| 2024 | Dysregulation of autophagy activation induced by atorvastatin contributes to new-onset diabetes mellitus in western diet-fed mice | METABOLISM-CLINICAL AND EXPERIMENTAL |
| 2024 | Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study | METABOLISM-CLINICAL AND EXPERIMENTAL |
| 2024 | Efficacy and Safety of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin as Metformin Add-on in a Korean Population with Type 2 Diabetes
| DIABETES THERAPY |
| 2024 | Intact ketogenesis predicted reduced risk of moderate-severe metabolic-associated fatty liver disease assessed by liver transient elastography in newly diagnosed type 2 diabetes
| FRONTIERS IN ENDOCRINOLOGY |
| 2023 | Efficacy and Safety of Enavogliflozin versus Dapagliflozin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus: A 24-Week, Double-Blind, Randomized Trial
| DIABETES & METABOLISM JOURNAL |
| 2023 | Cardiorenal Outcomes with Finerenone in Asian Patients with Chronic Kidney Disease and Type 2 Diabetes: A FIDELIO-DKD post hoc Analysis | AMERICAN JOURNAL OF NEPHROLOGY |
| 2023 | Safety and Clinical Outcomes of Insulin Degludec in Korean Patients with Diabetes in Real-World Practices: A Prospective, Observational Study
| DIABETES THERAPY |
| 2023 | Association between Impaired Ketogenesis and Metabolic-Associated Fatty Liver Disease
| BIOMOLECULES |
| 2023 | Glucometabolic control of once-weekly dulaglutide switched from DPP4 inhibitor versus daily empagliflozin add-on in patients with type 2 diabetes inadequately controlled with metformin, sulfonylurea, and DPP4 inhibitor: A randomised trial | DIABETES RESEARCH AND CLINICAL PRACTICE |
| 2023 | MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2023 | Metabolic dysfunction-associated fatty liver disease increases risk of chronic kidney disease: a systematic review and meta-analysis
| EGASTROENTEROLOGY |
| 2023 | Significance of Diabetic Kidney Disease Biomarkers in Predicting Metabolic-Associated Fatty Liver Disease
| BIOMEDICINES |
| 2023 | β-hydroxybutyrate as a biomarker of β-cell function in new-onset type 2 diabetes and its association with treatment response at 8 months | DIABETES & METABOLISM |
| 2023 | Tirzepatide versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo trial | NATURE MEDICINE |
| 2023 | Highly selective electrochemical quantitation of creatinine based on its chemical reaction with 3,5-dinitrobenzoate | JOURNAL OF ELECTROANALYTICAL CHEMISTRY |
| 2023 | Efficacy of Gemigliptin Add-on to Dapagliflozin and Metformin in Type 2 Diabetes Patients: A Randomized, Double-Blind, Placebo-Controlled Study (SOLUTION)
| Endocrinology and Metabolism(대한내분비학회지) |
| 2023 | Age at Mortality in Patients with Type 2 Diabetes Who Underwent Kidney Transplantation: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018
| JOURNAL OF CLINICAL MEDICINE |
| 2023 | Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes
| FRONTIERS IN ENDOCRINOLOGY |
| 2022 | Real-World Prescription Patterns and Barriers Related to the Use of Sodium-Glucose Cotransporter 2 Inhibitors among Korean Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease
| DIABETES & METABOLISM JOURNAL |
http://orcid.org/0000-0002-9899-4992
(15763315600)
